Literature DB >> 7944918

Fatigue secondary to chronic illness: postpolio syndrome, chronic fatigue syndrome, and multiple sclerosis.

T L Packer1, A Sauriol, B Brouwer.   

Abstract

Estimates of the percentage of patients with postpolio syndrome, chronic fatigue syndrome, and multiple sclerosis who experience fatigue range from approximately 75% to 100%. In this study we describe the severity of fatigue and its impact on subjects with these three diagnoses. The Fatigue Severity Scale, the Human Activity Profile, and the Nottingham Health Profile were used to measure fatigue, activity, and health status respectively of each diagnostic group as well as a control group. Using a Kruskal-Wallis one-way analysis of variance followed by a Bonferroni-adjusted Mann Whitney U test all diagnostic groups reported significantly higher levels (p = .0000 to p = .002) of fatigue and lower perceived health status than the control group. Subjects with chronic fatigue and multiple sclerosis also had significantly reduced activity levels (p = .002 to p = .01) compared with the control group. Further attention should be directed toward understanding the relationship between fatigue and ability to engage in activities as well as strategies for remediation and/or compensation of the fatigue.

Entities:  

Mesh:

Year:  1994        PMID: 7944918     DOI: 10.1016/0003-9993(94)90088-4

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

Review 1.  Recommendations for physical activity in patients with multiple sclerosis.

Authors:  J H Petajan; A T White
Journal:  Sports Med       Date:  1999-03       Impact factor: 11.136

2.  Outcome expectations and physical activity in persons with longstanding multiple sclerosis.

Authors:  Janet D Morrison; Alexa K Stuifbergen
Journal:  J Neurosci Nurs       Date:  2014-06       Impact factor: 1.230

3.  Long term outcome after poliomyelitis in different health and social conditions.

Authors:  T Rekand; J Kõrv; E Farbu; M Roose; N E Gilhus; N Langeland; J A Aarli
Journal:  J Epidemiol Community Health       Date:  2003-05       Impact factor: 3.710

4.  Differentiating Post-Polio Syndrome from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.

Authors:  Lauren Klebek; Madison Sunnquist; Leonard A Jason
Journal:  Fatigue       Date:  2019-11-06

5.  Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement.

Authors:  H L D Horemans; F Nollet; A Beelen; G Drost; D F Stegeman; M J Zwarts; J B J Bussmann; M de Visser; G J Lankhorst
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 6.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

7.  Exercise therapy and cognitive behavioural therapy to improve fatigue, daily activity performance and quality of life in postpoliomyelitis syndrome: the protocol of the FACTS-2-PPS trial.

Authors:  Fieke S Koopman; Anita Beelen; Karin H Gerrits; Gijs Bleijenberg; Tineke A Abma; Marianne de Visser; Frans Nollet
Journal:  BMC Neurol       Date:  2010-01-18       Impact factor: 2.474

8.  Muscle injections with lidocaine improve resting fatigue and pain in patients with chronic fatigue syndrome.

Authors:  Roland Staud; Taylor Kizer; Michael E Robinson
Journal:  J Pain Res       Date:  2017-06-26       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.